{"product_id":"amp-2024-annual-meeting-expo-recordings","title":"AMP 2024 Annual Meeting \u0026 Expo Recordings","description":"\u003ch1 class=\"product-title product_title entry-title\"\u003eAMP 2024 Annual Meeting \u0026amp; Expo Recordings\u003c\/h1\u003e\r\n\u003ch5\u003e\u003cstrong\u003e\u003cem\u003eThis collection will give you access to many of the sessions recorded at the 2024 AMP Annual Meeting \u0026amp; Expo Virtual  Meeting and the associated pdf slides. \u003c\/em\u003e\u003cem\u003eCME and CMLE is available for select sessions in this collection. \u003c\/em\u003e\u003c\/strong\u003e\u003c\/h5\u003e\r\n\u003ch4\u003e\u003cstrong\u003e list of files \u003c\/strong\u003e\u003c\/h4\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003eE:.\u003c\/div\u003e\r\n\u003cdiv\u003e    (G004) Diagnosis of Germline and Somatic Mismatch Repair Deficient Cancers by Low-Pass Whole Genome Sequencing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (G017) Cell-Free DNA Assay Detects Low Level Mosaicism in Individuals With Retinoblastoma.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (G038) Quality Assessment of SERPINA1 Genotyping and A1AT Serum Concentration Testing An 11-Year Review of Clinical Results.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (G064) INT2GRATE Oncology Consortium A Novel Variant Evidence Framework for Cancer Syndromes and Data-Sharing Platform for Integrated Germline and Tumor Variants.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (H014) Evaluation of T-cell Immunotranscriptomic Profiling in Lymphoid Neoplasms.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (H018) Measuring T-cell Diversity Alongside Clonality May Prove Clinically Useful for Patients Undergoing NGS-based T-cell Receptor Gamma Gene (TRG) Rearrangement Testing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (H023) Clinical Utility of Optical Genome Mapping as an Addition to Standard Cytogenetic Workup in Hematological Malignancies.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (H036) FNIH MRD in AML Biomarkers Consortium Evaluation of Methods for Detection of FLT3 Internal Tandem Duplication Measurable Residual Disease in Acute Myeloid Leukemia.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (I010) AI-driven Discovery of Morphomolecular Signatures in Toxicology.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (I012) Unexpected Detection of Viral Nucleic Acid in Targeted RNA-based Next Generation Sequencing Fusion Assays for Clinical Oncology.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (I015) Application and Lessons Learned from Curating 100 Somatic Cancer Variants Using the ClinGenCGCVICC Guidelines in a Pediatric Hospital Setting..pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (I034) Predicting Cytomegalovirus Viral Load From Next-generation Sequencing Data A Machine Learning Approach.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (ID020) Housekeeping Gene Specimen Adequacy Controls are Poor Proxies for Nasopharyngeal Swab Collection Quality.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (ID030) Targeted Next Generation Sequencing for Improved Identification of Bacterial and Fungal Pathogens in Formalin-Fixed Paraffin-Embedded Tissue.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (ID058) Product Alert Corrective Action Norovirus False Positive Results with the Biofire Molecular Gastrointestinal Pathogens Test.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (ID059) Rapid Nanopore Genotyping for Bacterial Antimicrobial Susceptibility Prediction.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (ST057) Clinical Utility of Whole Transcriptome Sequencing by RNA-Seq for Detection of Fusions in Targeted-NGS Negative Samples.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (ST120) Methylation-Based Droplet Digital PCR Separates Pulmonary Mucinous Adenocarcinomas From Pancreatic Metastases to the Lung.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (TT002) A Modified FLT3 PCR Assay Using TapeStation Readout.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (TT016) Evaluation of an Automated DNA Extraction Platform.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (TT021) Clinical Validation of a Custom-designed Large Gene Fusion Panel for Solid Tumors.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (TT044) Evaluation of NPM1 Drop Off Droplet Digital PCR Assay for Minimal Residual Disease Detection in Acute Myeloid Leukemia patients.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (TT057) Predicting DNARNA Extraction Yields for NGS Using Machine Learning-Based Analysis of HE-Stained Slides.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    (TT074) Validation of a Rapid Targeted Next Generation Sequencing Oncology Panel.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    21st Century Diagnostic Parasitology   The Roles that Nucleic Acid Tests Play in Parasite Detection, Characterization, and Surveillance (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    A Blastoid Mystery Low-Grade Origins, High-Grade Evolution.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    A Rare Case of Infant Type Hemispheric Glioma with Aggressive Course and Novel Targetable PRKAR2AALK fusion.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    A RefResher in Laboratory Statistics Using R in Validations and Verifications.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    A RefResher in Laboratory Statistics- Using R in Validations and Verifications.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    A RefResher in Laboratory Statistics- Using R in Validations and Verifications[2].mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Acute Myeloid Leukemia With t(8; 16)(p11; p13)KAT6ACREBBP Identified by Whole-Genome Sequencing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Advances in Characterizing Structural Chromosomal Alterations (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Advancing Genomic Medicine Leveraging Large Language Models and Polygenic Risk Scores in Clinical Practice.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    AML MRD Analysis Using FLT3-ITD.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    AMP-ACMG-CPIC-CAP-DPWG-ESPT-PharmGKB-PharmVar DPYD Genotyping Recommendations (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    AMP-CAP-NSGC Slice Testing Considerations from Ordering to Reporting (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    AMP-CAP-SITC Recommendations for Tumor Mutational Burden Assay Validation and Reporting (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    AMPACMGCPICCAPDPWGESPTPharmGKBPharmVar DPYD Genotyping Recommendations.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    AMPCAPNSGC Slice Testing Considerations from Ordering to Reporting.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    AMPCAPSITC Recommendations for Tumor Mutational Burden Assay Validation and Reporting.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    An Infectious Diseases Diagnostics Journey From Gram Stain to Next Generation Sequencing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Analytics, Informatics, AI and the Expanding Role of the Clinical Laboratorian (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Award for Excellence Recognition and 30 Years of Excellence.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Bridging the Dimensions- Unleashing the Power of Deep Learning in Precision Medicine (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Case Studies in Genetics (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Case Studies in Hematopathology (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Case Studies in Hematopathology and Infectious Diseases (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Case Studies in Solid Tumors I (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Case Studies in Solid Tumors II (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    cfDNA in Early Detection of Hematologic malignancies.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Clinical Cancer Whole Exome and Transcriptome Sequencing Lessons learned over 10 years and future outlook.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Clinical Microbiology Automation Past, Present, and Future.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Clinical Microbiology Meets AI A Look Back, a Look at the Present, and a Look Ahead.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Clinical Practice Guidelines for the Screening for Autosomal Recessive and X-linked Conditions.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Clinical Validation and Implementation of Somatic Whole Exome Sequencing (WES) and Whole Transcriptome Sequencing (WTS) for Solid Tumors and Hematopoietic Neoplasms..pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Clonal Hematopoiesis Background and Clinical Significance.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Comprehensive Genomic Testing as a Tool for Robust Characterization of Putative Splice Site Variants An Illustrative Case.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Considerations for the Evaluation of Acquired Variants in the Germline Genetic Testing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Cost-Effectiveness, Economic, and Business Considerations for Point-ofCare, At Home, and Home Collection Testing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Crafting the Blueprint Standards Building and Policymaking for Clinical AI.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Developing Open-Source Bioinformatics Pipelines and Packages for Molecular Pathology.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Disparities in Genetic Testing (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Distinct Atypical Meningiomas Hiding in Plain Sight, Out SMARC d by SMARCB1.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    EAC Townhall 2024 Review of EAC Activities  Legislative Efforts.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    EAC Townhall- 2024 Review of EAC Activities \u0026amp; Legislative Efforts – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    EGFR Exon 20 Insertion Mutation as the Defining Genomic Alteration and Grade Determination in a Diffuse Thalamic Glioma.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Exploration of Emerging Informatics Innovations (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Extramedullary NPM1+ Acute Myeloid Leukemia Transformation in the Setting of  Chronic Phase  Primary Myelofibrosis in the Bone Marrow.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    FDA Perspectives on Molecular at Home and Point of Care Testing for Infectious Diseases.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Fine-Tuning Large Language Models to Facilitate Precision Medicine.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    From Pathology to the Biobank- Considerations for Managing Laboratory Samples and Data (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Genome in a Bottle Benchmarks for Training and Testing AI-Based Variant Callers.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Genomic Analysis as a Precision Tool for Daily Diagnostic Challenges First Case Report Showing Definitive Molecular Evidence for Distant Drop Metastasis of Colonic Adenocarcinoma.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Global Disparities in Genetic Testing and Molecular Diagnostics for Cancer Charting an Equitable Path Forward.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    How Labs Can Be Allies Why Language Matters for Testing Accuracy and Patient Experience.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Human Tumor Atlas Network Mapping Tumor Transitions at Molecular Resolution.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Human Tumor Atlas Network- Mapping Tumor Transitions at Molecular Resolution (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Identifying the Signal in the Signal Incidental Detection of B-Cell Lymphoma Related Variants in the Molecular Profiling of a Spindle Cell Sarcoma.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Implementation of Carrier Screening for Autosomal Recessive and X-linked disorders – Clinical Practice and Laboratory Perspectives (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Incidental Detection of Acquired Variants in Germline Genetic Testing (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Incidental Discovery of a Sex Chromosome Disorder During Somatic Testing in a Phenotypically Male Lung Cancer Patient A Multidisciplinary Dilemma.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Insights From the Lab Leveraging Data Analytics in the Clinical Laboratory.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Integrating At-Home and Point-of-Care Testing into Clinical Care Impacts on Physician Decision-Making in Real-World Settings.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Laboratory Automation- Key Considerations for Implementation (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Laboratory Considerations for the Incidental Detection of Acquired Variants in Germline Genetic Testing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Laboratory Perspectives for Carrier Screening for Autosomal Recessive and X-Linked Disorders.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Language of Innovation- Navigating Large Language Models in Healthcare – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Liquid Biopsy Guides Diagnostic Algorithm in a Case With Two Metasynchronous Primary Tumors.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Long Read Sequencing The Long and Short of It..pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Mechanisms of Viral-Host Cell Interaction Integration, Mutagenesis and Tumorigenesis.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Microbiome Discovery and Characterization from Next Generation Sequencing Data.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Molecular at Home and Point of Care Testing for Infectious Diseases (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Molecular Diagnosis of Bordatella A Case of Confusion With B. bronchiseptica.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Molecular Profiling is a Helpful Tool in Diagnosing MMNST.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Multimodal Approach for the Diagnosis of Placental Mesenchymal Dysplasia.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Multiplex Infectious Disease Molecular Panels Technology and Challenges.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Multiplex Syndromic Panels Challenges and Opportunities for Reimbursement.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Navigating the Challenges of Identifying the Causative CICDUX4 Gene Fusion Using Whole Transcriptome RNA Sequencing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Navigating the Data Landscape Practical Applications of Analytics in the Clinical Laboratory.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Navigating the Landscape of Open Source Tools for Applications in Molecular Pathology (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    New Molecular Genomic Discoveries in B-Cell Neoplasms and Clinical Applications (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Novel FANCD2 Variant Leading to Somatic Rescue in a Patient With Fanconi Anemia.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Novel Mechanisms of Lymphomagenesis and Transformation From Functional Proteogenomics.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Nucleic Acid Testing for Parasite Detection, Characterization, and Surveillance.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Open-Source Bioinformatics Pipelines and Packages for Infectious Diseases.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Opening Remarks.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Optical Genome Mapping – A New Age in Cytogenetics.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Optical Genome Mapping Complemented With DNA Sequencing Detects Prognostic Markers in a Rare T-Cell Leukemia and Refines the Cytogenetics Work-Up.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003e    Pathology, Sample Collection and the Biobanking Continuum in Healthcare Research.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Platform Presentations of Selected Genetics Abstracts (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Platform Presentations of Selected Hemepath Abstracts (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Platform Presentations of Selected Infectious Diseases Abstracts (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Platform Presentations of Selected Informatics Abstracts (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Platform Presentations of Selected Solid Tumors Abstracts (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Platform Presentations of Selected Tech Topics Abstracts (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Plenary – Opening Remarks, AFE Recognition, and 30 Years of Excellence.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Plenary – Opening Remarks, AFE Recognition, and 30 Years of Excellence[2].mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Professional Relations Committee (PRC) Discusses AMP Lawsuit Against FDA Challenging Oversight of Lab Developed Testing Procedures (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Professional Relations Committee (PRC) Discusses AMP Lawsuit Against FDA Challenging Oversight of Lab Developed Testing Procedures.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Profiling Cell-Free DNA in Lymphoma MRD and Beyond.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Quantification of Measurable Residual Disease in Adults with Acute Myeloid Leukemia.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Radiogenomics Integrating Molecular and Imaging Data in Cancer Diagnosis  Treatment.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Radiogenomics Integrating Molecular and Imaging Data in Cancer Diagnosis.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Radiogenomics- Integrating Molecular and Imaging Data in Cancer Diagnosis (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Role of Gender Identification in Genetic Testing (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Role of Sex and Gender in Clinical Oncology and Medical Genetics.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Sex and Gender in Medicine The Basics.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Standardization Efforts for AI (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Strategies and Challenges of Measurable Residual Disease Testing in Acute Myeloid Leukemia – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Syndromic Panels for Infectious Disease Diagnosis (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Technologist Innovation Session (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    The Global Burden of Fungal Diseases An Urgent Need for Advanced Diagnostics.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    The Journey of Infectious Disease Diagnostics- From Gram Stain to Next Generation Sequencing (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    The Molecular Twin Artificial-Intelligence Platform in Precision Oncology.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    There s a Fungus Among Us! Next-Generation Molecular Testing in Diagnostic Mycology (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Unmasking the Unexpected A Case of Silent PNH in a Young Woman.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Unraveling Complexity the Clinical Benefits and Challenges of Syndromic Panel Testing.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Unveiling Viral Associations in Human Cancer Using Genomic Data (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    Utilization of Cell Free DNA in Characterization and Detection of Minimal Residual Disease in Lymphoid Malignancies (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e    What Can Multiplex PCR and Targeted Next Generation Sequencing Tell Us About Parasitic Infections and Outbreaks.pdf\u003c\/div\u003e\r\n\u003cdiv\u003e    Whole Exome Sequencing in Solid Tumors – the Changing Paradigm of Clinical Oncology (2024) – AMP.mp4\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003cdiv\u003eNo subfolders exist\u003c\/div\u003e\r\n\u003cdiv\u003e\u003c\/div\u003e\r\n\u003ctable\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cimg class=\"img-fluid atto_image_button_text-bottom\" role=\"presentation\" src=\"https:\/\/shop.amp.org\/amp-2024-annual-meeting-expo-recordings\/@@PLUGINFILE@@\/General%20Information.png\" alt=\"\" width=\"200\" height=\"200\"\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\n\u003cstrong\u003eAccess the Future of Molecular Diagnostics Anytime!\u003c\/strong\u003e\r\nExplore the cutting-edge content from the AMP Annual Meeting, the premier event for molecular professionals. This enduring program offers critical updates and expert insights to help you stay ahead in delivering the best patient care.Delve into a strong focus on artificial intelligence, including standardization efforts, large language models in healthcare, and the role of clinical laboratorians. Explore carrier screening, minimal residual disease in leukemia and lymphoid malignancies, laboratory automation, the Human Tumor Atlas Network, and genomics’ role in uncovering viral links to cancer.With timely contributions from AMP Working Groups and Committees, this program is your key to advancing your knowledge in molecular diagnostics.\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003ch1 class=\"product-title product_title entry-title\"\u003e\u003c\/h1\u003e","brand":"My Store","offers":[{"title":"Default Title","offer_id":42954572922978,"sku":"MED-AMB06379","price":70.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/AMP-2024-Annual-Meeting-Expo-Recordings.webp?v=1779379978","url":"https:\/\/meducourse.com\/products\/amp-2024-annual-meeting-expo-recordings","provider":"Meducourse","version":"1.0","type":"link"}